Medtronic (MDT)

Add to Watchlists Create an Alert
51.33 -0.13  -0.25%   NYSE May 24, 8:00PM BATS Real time Currency in USD

Medtronic R&D Expense Quarterly:

376.00M for Jan. 31, 2013
View Full Chart

Medtronic R&D Expense Quarterly Chart

    Medtronic Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Jan. 31, 2013 376.00M
    Oct. 31, 2012 387.00M
    July 31, 2012 385.00M
    April 30, 2012 393.00M
    Jan. 31, 2012 364.00M
    Oct. 31, 2011 371.00M
    July 31, 2011 362.00M
    April 30, 2011 385.00M
    Jan. 31, 2011 362.00M
    Oct. 31, 2010 373.00M
    July 31, 2010 370.00M
    April 30, 2010 377.00M
    Jan. 31, 2010 344.00M
    Oct. 31, 2009 369.00M
    July 31, 2009 370.00M
    April 30, 2009 368.00M
    Jan. 31, 2009 337.00M
    Oct. 31, 2008 326.00M
    July 31, 2008 324.00M
    April 30, 2008 Go Pro
    Jan. 31, 2008 Go Pro
    Oct. 31, 2007 Go Pro
    July 31, 2007 Go Pro
    April 30, 2007 Go Pro
    Jan. 31, 2007 Go Pro
       
    Oct. 31, 2006 Go Pro
    July 31, 2006 Go Pro
    April 30, 2006 Go Pro
    Jan. 31, 2006 Go Pro
    Oct. 31, 2005 Go Pro
    July 31, 2005 Go Pro
    April 30, 2005 Go Pro
    Jan. 31, 2005 Go Pro
    Oct. 31, 2004 Go Pro
    July 31, 2004 Go Pro
    April 30, 2004 Go Pro
    Jan. 31, 2004 Go Pro
    Oct. 31, 2003 Go Pro
    July 31, 2003 Go Pro
    April 30, 2003 Go Pro
    Jan. 31, 2003 Go Pro
    Oct. 31, 2002 Go Pro
    July 31, 2002 Go Pro
    April 30, 2002 Go Pro
    Jan. 31, 2002 Go Pro
    Oct. 31, 2001 Go Pro
    July 31, 2001 Go Pro
    April 30, 2001 Go Pro
    Jan. 31, 2001 Go Pro
    Oct. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    MDT R&D Expense Quarterly Benchmarks

    Companies
    Boston Scientific 204.00M
    St Jude Medical 160.00M
    Zimmer 53.50M

    MDT R&D Expense Quarterly Rankings

    Overall 99th percentile
    49 of 7600
    Sector 97th percentile
    15 of 653 in Healthcare
    Industry 98th percentile
    1 of 90 in Medical Devices

    MDT R&D Expense Quarterly Range, Past 5 Years

    Minimum 324.00M Jul 2008
    Maximum 393.00M Apr 2012
    Average 365.42M